Internal Medicine, Cardiovascular Disease · Albany, NY
NPI
1548444664
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
7 Southwoods Blvd, Capital Cardiology Associates PC
Albany, NY, 12211
Phone (518) 292-6000
Groups this clinician bills Medicare through
Medicare paid, 2024
$818K
24,225 services
Medicare patients, 2024
1,992
Average age 75
Drug cost, 2024
$3.4M
16,426 prescriptions
Company payments, 2025
$845
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey R Uzzilia was code J1306 (injection, inclisiran, 1 mg), 7,100 times for 14 patients. In total Jeffrey R Uzzilia billed 24,225 services in 103 codes, and Medicare paid $818K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1306 Injection, inclisiran, 1 mg | Office | 7,100 | 14 | $9.49 | $67K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 3,881 | 43 | $0.10 | $394 |
| 93000 Electrocardiogram | Office | 1,347 | 1,053 | $9.90 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,342 | 1,032 | $11.50 | $15K |
| 99214 Office E&M - Established | Office | 1,302 | 1,016 | $83.76 | $109K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 1,109 | 320 | $47.15 | $52K |
| 99457 E&M - Miscellaneous | Office | 986 | 288 | $37.03 | $37K |
| 99454 E&M - Miscellaneous | Office | 676 | 248 | $35.37 | $24K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 564 | 140 | $4.54 | $2,560 |
| 93010 Electrocardiogram | Facility | 453 | 347 | $6.13 | $2,776 |
| 36415 Venipuncture Blood Collection | Office | 435 | 312 | $8.65 | $3,763 |
| 80053 Clinical Chemistry | Office | 304 | 252 | $10.35 | $3,146 |
| 99458 E&M - Miscellaneous | Office | 284 | 111 | $29.41 | $8,352 |
| 85025 Blood Count | Office | 271 | 232 | $7.61 | $2,062 |
| 93306 Echocardiography (TTE/TEE) | Office | 264 | 251 | $135.13 | $36K |
By year: 2022 $689K for 16,695 services; 2023 $726K for 21,647 services; 2024 $818K for 24,225 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 435 | 312 | $8.65 | $3,763 |
| 80053 Clinical Chemistry | 304 | 252 | $10.35 | $3,146 |
| 85025 Blood Count | 271 | 232 | $7.61 | $2,062 |
| 83880 Clinical Chemistry | 257 | 175 | $38.47 | $9,887 |
| 80061 Clinical Chemistry | 203 | 189 | $13.12 | $2,663 |
| 84443 Clinical Chemistry | 194 | 183 | $16.46 | $3,193 |
| 83735 Clinical Chemistry | 138 | 114 | $6.57 | $907 |
| 84484 Clinical Chemistry | 115 | 102 | $12.22 | $1,405 |
| 80048 Clinical Chemistry | 92 | 55 | $8.29 | $763 |
| 86141 Clinical Chemistry | 82 | 81 | $12.69 | $1,041 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey R Uzzilia prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,798 prescriptions and refills. In total Jeffrey R Uzzilia wrote 16,426 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,798 | 5,191 | 561 | $20K |
| Rosuvastatin Calcium Generic | 1,576 | 4,568 | 502 | $23K |
| Metoprolol Succinate Generic | 1,339 | 3,828 | 411 | $22K |
| Eliquis Apixaban | 980 | 2,471 | 289 | $1.4M |
| Amlodipine Besylate Generic | 976 | 2,771 | 309 | $5,161 |
| Losartan Potassium Generic | 775 | 2,208 | 249 | $7,637 |
| Lisinopril Generic | 645 | 1,900 | 198 | $4,673 |
| Carvedilol Generic | 591 | 1,674 | 184 | $5,301 |
| Clopidogrel Clopidogrel Bisulfate | 582 | 1,633 | 177 | $7,256 |
| Hydrochlorothiazide Generic | 574 | 1,653 | 173 | $3,640 |
| Furosemide Generic | 445 | 1,069 | 158 | $1,745 |
| Metoprolol Tartrate Generic | 413 | 1,076 | 115 | $2,093 |
| Nifedipine Er Nifedipine | 339 | 946 | 110 | $10K |
| Ezetimibe Generic | 312 | 900 | 103 | $8,972 |
| Bumetanide Generic | 310 | 841 | 109 | $9,014 |
Brand drugs: 2,062 claims; generic drugs: 14,364 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey R Uzzilia $845 ($845 in general payments such as food, travel and fees) from 10 companies. The largest payer was AOP Health US, LLC with $265.
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $265 |
| Novartis Pharmaceuticals Corporation NVS | 24 | $205 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $122 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $89.17 |
| BridgeBio Pharma, Inc. BBIO | 2 | $43.8 |
| Genzyme Corporation SNY | 1 | $32.43 |
| Pfizer Inc. PFE | 1 | $25.8 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25.71 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $22.82 |
| Amgen Inc. AMGN | 1 | $13.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.